254 related articles for article (PubMed ID: 12942537)
1. Survivin study: what is the next wave?
Li F
J Cell Physiol; 2003 Oct; 197(1):8-29. PubMed ID: 12942537
[TBL] [Abstract][Full Text] [Related]
2. Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.
Chiou SK; Jones MK; Tarnawski AS
Med Sci Monit; 2003 Apr; 9(4):PI25-9. PubMed ID: 12709681
[TBL] [Abstract][Full Text] [Related]
3. Survivin: a bifunctional inhibitor of apoptosis protein.
Johnson ME; Howerth EW
Vet Pathol; 2004 Nov; 41(6):599-607. PubMed ID: 15557069
[TBL] [Abstract][Full Text] [Related]
4. Survivin, versatile modulation of cell division and apoptosis in cancer.
Altieri DC
Oncogene; 2003 Nov; 22(53):8581-9. PubMed ID: 14634620
[TBL] [Abstract][Full Text] [Related]
5. Survivin-dependent and -independent pathways and the induction of cancer cell death by tetra-O-methyl nordihydroguaiaretic acid.
Huang RC; Chang CC; Mold D
Semin Oncol; 2006 Aug; 33(4):479-85. PubMed ID: 16890802
[TBL] [Abstract][Full Text] [Related]
6. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
Mita AC; Mita MM; Nawrocki ST; Giles FJ
Clin Cancer Res; 2008 Aug; 14(16):5000-5. PubMed ID: 18698017
[TBL] [Abstract][Full Text] [Related]
7. The universal character of the tumor-associated antigen survivin.
Andersen MH; Svane IM; Becker JC; Straten PT
Clin Cancer Res; 2007 Oct; 13(20):5991-4. PubMed ID: 17947459
[TBL] [Abstract][Full Text] [Related]
8. Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm.
Altieri DC
J Cell Biochem; 2004 Jul; 92(4):656-63. PubMed ID: 15211564
[TBL] [Abstract][Full Text] [Related]
9. Targeting survivin in cancer therapy: fulfilled promises and open questions.
Pennati M; Folini M; Zaffaroni N
Carcinogenesis; 2007 Jun; 28(6):1133-9. PubMed ID: 17341657
[TBL] [Abstract][Full Text] [Related]
10. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential.
Stauber RH; Mann W; Knauer SK
Cancer Res; 2007 Jul; 67(13):5999-6002. PubMed ID: 17616652
[TBL] [Abstract][Full Text] [Related]
11. Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin.
Hu H; Shikama Y; Matsuoka I; Kimura J
J Leukoc Biol; 2008 Feb; 83(2):393-400. PubMed ID: 17965335
[TBL] [Abstract][Full Text] [Related]
12. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
Sharma H; Sen S; Mathur M; Bahadur S; Singh N
Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
[TBL] [Abstract][Full Text] [Related]
13. Survivin: an inhibitor of apoptosis in pediatric cancer.
Fangusaro JR; Caldas H; Jiang Y; Altura RA
Pediatr Blood Cancer; 2006 Jul; 47(1):4-13. PubMed ID: 16534789
[TBL] [Abstract][Full Text] [Related]
14. Structural, functional and therapeutic biology of survivin.
Sah NK; Khan Z; Khan GJ; Bisen PS
Cancer Lett; 2006 Dec; 244(2):164-71. PubMed ID: 16621243
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization of Survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax.
Temme A; Rodriguez JA; Hendruschk S; Günes S; Weigle B; Schäkel K; Schmitz M; Bachmann M; Schackert G; Rieber EP
Cancer Lett; 2007 Jun; 250(2):177-93. PubMed ID: 17084966
[TBL] [Abstract][Full Text] [Related]
16. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
Capalbo G; Rödel C; Stauber RH; Knauer SK; Bache M; Kappler M; Rödel F
Strahlenther Onkol; 2007 Nov; 183(11):593-9. PubMed ID: 17960333
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance and different properties of survivin splicing variants in gastric cancer.
Meng H; Lu C; Mabuchi H; Tanigawa N
Cancer Lett; 2004 Dec; 216(2):147-55. PubMed ID: 15533590
[TBL] [Abstract][Full Text] [Related]
19. Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.
Caldas H; Honsey LE; Altura RA
Mol Cancer; 2005 Mar; 4(1):11. PubMed ID: 15743529
[TBL] [Abstract][Full Text] [Related]
20. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
